...Gemayel is also chairman of Enterome Bioscience S.A. (Paris, France), Orphazyme A/S (Copenhagen, Denmark) and OxThera AB...

...Kubik as CBO. He was CBO of i2 Pharmaceuticals Inc. (Boulder, Colo.). Rare disease company OxThera AB...

...innovative medicines at the MedImmune LLC subsidiary of AstraZeneca plc (LSE:AZN; NYSE:AZN). Rare disease company OxThera AB...

...Anthony Lombardo will be interim CEO while the company seeks a replacement. Rare disease company OxThera AB...

...investors Kurma Partners, Idinvest Partners, Stiftelsen Industrifonden and Brohuvudet also participated. OxThera AB , Uppsala, Sweden Alicia Parker OxThera AB...

...Flerie Invest. Also participating were existing investors Kurma Partners, Idinvest Partners, Stiftelsen Industrifonden and Brohuvudet. OxThera...
...short bowel syndrome (SBS). It is a capsule formulation of lyophilized live Oxalobacter formigenes . Chris Lieu Oxabact OxThera AB...

...The European Commission granted Orphan Drug designation to Oxabact from OxThera to treat short bowel syndrome...
...U.S. to treat primary hyperoxaluria, for which the compound is in a Phase II trial. OxThera AB...

...primary hyperoxaluria. Oxabact has Orphan Drug designation for the indication in the EU and U.S. OxThera AB...